Recovery of sperm quality after COVID‐19 disease in male adults under the influence of a micronutrient combination: A prospective study
Accepted: January 29, 2023
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Objective: This study aims to evaluate the safety and efficacy of a standard micronutrient preparation to improve semen parameters and seminal oxidative stress in adult male subjects after Coronavirus Disease 2019 (COVID-19) disease.
Methods: For this prospective pilot study, 30 males aged 20-50 years who had recently recovered from a symptomatic SARS-CoV-2 infection were recruited from June to October 2021 through a public call for participation. Participants of the study group (n = 30) received two semen analyses according to WHO criteria at an interval of 12 weeks, during which they daily received a micronutrient preparation (L-carnitine, L-arginine, coenzyme Q10, vitamin E, zinc, folic acid, glutathione and selenium). Changes in major semen variables and seminal oxidative stress levels before and after therapy were analyzed and compared to a control group (n = 10) adhering to the same inclusion criteria, including subjects who recently recovered from symptomatic COVID-19 disease without micronutrient supplementation within the 12 weeks between the two semen analyses.
Results: After 3 months of micronutrient supplementation the rate of normal semen analysis results in the study group increased significantly (p = 0.009) by 66.7%: from 50.0% before to 83.3% after therapy. There was a significant increase in progressive (p = 0.014) and overall motility (p = 0.05) as well as in the vitality (p = 0.0004) of semen cells after 12 weeks of micronutrient intake. In the control group there were no significant changes in any semen parameter or in the rate of normal semen analysis results over the 3-month observation period. In both groups, sperm density, morphology and oxidative stress did not improve significantly.
Conclusions: Our data suggests that supplementation of certain micronutrients may be a safe way to support recovery of impaired semen parameters in male adults recovered from COVID-19 disease.
After receiving her Bachelors degree in chemistry in 2017, Judith Aschauer started to study medicine at the Medical University of Vienna, from which she will graduate in June 2023. Since the beginning of her studies she has been working at the semen analysis laboratory of the IMI fertility clinic in Vienna. This clinic also serves as an important research site for the independent medical-scientific research institution "Karl Landsteiner Society". Judith Aschauer has participated in the planning, execution and publication of various studies regarding factors influencing male fertility and possibilities to improve semen quality, which is content of her graduate thesis at the Medical University of Vienna. The Karl Landsteiner Society currently comprising 65 Institutes covering almost all fields of medicine.
Univ. Prof. Martin Imhof (M.D., Ph.D.)
Medical studies in Vienna (-1993). Residency at the Univ. Dep. for Heart- and Thoracic Surgery, General Surgrey and Gynaecology/Obstetric, Member of the In Vitro Fertilisation Team, 2004 Specialist for Obstetrics and Gynaecology, 2006 Venia Docendi, 2009
Head of Department and Medical Director at the General Public Teaching Hospital Korneuburg/Vienna. Head of Karl Landsteiner Institute for Cell-Focussed Therapy. Scientific activities: Umbilical Stem Cells, Ovarian Tissue Banking, Tumor therapy with Dendritic Cells, Micronutrients and Phytohormones in fertility.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.